These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37927156)

  • 21. Posttraumatic Stress Disorder After a Psychedelic Experience, a Case Report.
    Rubin-Kahana DS; Hassan AN; Le Foll B
    J Addict Med; 2021 May-Jun 01; 15(3):248-251. PubMed ID: 32925231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescribing meaning: hedonistic perspectives on the therapeutic use of psychedelic-assisted meaning enhancement.
    Miceli McMillan R
    J Med Ethics; 2021 Oct; 47(10):701-705. PubMed ID: 33148774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.
    Stein CA; Penn A; Van Hope S; Dorsen CG; Mangini M
    J Midwifery Womens Health; 2022 May; 67(3):373-383. PubMed ID: 35522087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature.
    Michaels TI; Purdon J; Collins A; Williams MT
    BMC Psychiatry; 2018 Jul; 18(1):245. PubMed ID: 30064392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
    Barber GS; Dike CC
    Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.
    Holoyda B
    Psychiatr Serv; 2020 Dec; 71(12):1297-1299. PubMed ID: 33050796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.
    Carhart-Harris RL; Leech R; Williams TM; Erritzoe D; Abbasi N; Bargiotas T; Hobden P; Sharp DJ; Evans J; Feilding A; Wise RG; Nutt DJ
    Br J Psychiatry; 2012 Mar; 200(3):238-44. PubMed ID: 22282432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Emerging Field of Psychedelic Psychotherapy.
    Barber GS; Aaronson ST
    Curr Psychiatry Rep; 2022 Oct; 24(10):583-590. PubMed ID: 36129571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.
    Pearson C; Siegel J; Gold JA
    J Neurol Sci; 2022 Mar; 434():120096. PubMed ID: 34942586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice.
    Gobbi G; Inserra A; Greenway KT; Lifshitz M; Kirmayer LJ
    Transcult Psychiatry; 2022 Oct; 59(5):718-724. PubMed ID: 36263521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychedelic-assisted psychotherapy, patient vulnerability and abuses of power.
    Meikle S; Carter O; Bedi G
    Aust N Z J Psychiatry; 2024 Feb; 58(2):104-106. PubMed ID: 37767944
    [No Abstract]   [Full Text] [Related]  

  • 32. Ethical Considerations at the Intersection Between Psychedelic-Assisted Psychotherapy and Medical Assistance in Dying.
    Rosenbaum D; Cho M; Schneider E; Hales S; Buchman DZ
    AJOB Neurosci; 2023; 14(2):139-141. PubMed ID: 37097844
    [No Abstract]   [Full Text] [Related]  

  • 33. Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials.
    Aday JS; Heifets BD; Pratscher SD; Bradley E; Rosen R; Woolley JD
    Psychopharmacology (Berl); 2022 Jun; 239(6):1989-2010. PubMed ID: 35359159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.
    Rosenblat JD; Leon-Carlyle M; Ali S; Husain MI; McIntyre RS
    Am J Psychiatry; 2023 May; 180(5):395-396. PubMed ID: 36945824
    [No Abstract]   [Full Text] [Related]  

  • 35. MDMA-assisted psychotherapy for post-traumatic stress disorder: The devil is in the detail.
    Bedi G; Cotton SM; Guerin AA; Jackson HJ
    Aust N Z J Psychiatry; 2023 Apr; 57(4):476-481. PubMed ID: 36165006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a case for MDMA-assisted psychotherapy in the UK?
    Sessa B
    J Psychopharmacol; 2007 Mar; 21(2):220-4. PubMed ID: 17329304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotherapy with hallucinogenic adjuncts from a learning perspective.
    Grieco A; Bloom R
    Int J Addict; 1981 Jul; 16(5):801-27. PubMed ID: 7327766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. More than meets the eye: The role of sensory dimensions in psychedelic brain dynamics, experience, and therapeutics.
    Aqil M; Roseman L
    Neuropharmacology; 2023 Feb; 223():109300. PubMed ID: 36334767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine.
    Averill LA; Abdallah CG
    Expert Opin Investig Drugs; 2022 Feb; 31(2):133-137. PubMed ID: 35188023
    [No Abstract]   [Full Text] [Related]  

  • 40. Reply to "Capturing Synergy Holistically in Psychedelic Clinical Trials".
    Dworkin RH; McDermott MP; Nayak SM; Strain EC
    Clin Pharmacol Ther; 2024 Mar; 115(3):401-402. PubMed ID: 38087954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.